BTC $64,420.50 -0.34%
ETH $1,806.30 -0.62%
BNB $592.92 +0.30%
XRP $0.9751 +2.06%
SOL $74.47 +3.95%
TRX $0.3080 +0.85%
DOGE $0.0593 +0.98%
ADA $0.1530 +0.56%
BCH $209.52 +0.82%
LINK $9.21 +1.12%
HYPE $68.98 +0.21%
AAVE $111.77 +2.49%
SUI $0.7284 +1.97%
XLM $0.1401 +2.40%
ZEC $956.24 +5.41%
AAPL $350.22 -1.02%
AMZN $259.08 -0.12%
GOOGL $282.75 -0.87%
MSFT $508.16 -2.58%
META $619.71 -1.27%
NVDA $159.65 +1.41%
TSLA $383.14 +0.53%
SNDK $822.00 +0.09%
INTC $55.70 +2.16%
SPCX $142.22 +2.95%
MU $731.55 +0.30%
AMD $511.24 -0.59%
BTC $64,420.50 -0.34%
ETH $1,806.30 -0.62%
BNB $592.92 +0.30%
XRP $0.9751 +2.06%
SOL $74.47 +3.95%
TRX $0.3080 +0.85%
DOGE $0.0593 +0.98%
ADA $0.1530 +0.56%
BCH $209.52 +0.82%
LINK $9.21 +1.12%
HYPE $68.98 +0.21%
AAVE $111.77 +2.49%
SUI $0.7284 +1.97%
XLM $0.1401 +2.40%
ZEC $956.24 +5.41%
AAPL $350.22 -1.02%
AMZN $259.08 -0.12%
GOOGL $282.75 -0.87%
MSFT $508.16 -2.58%
META $619.71 -1.27%
NVDA $159.65 +1.41%
TSLA $383.14 +0.53%
SNDK $822.00 +0.09%
INTC $55.70 +2.16%
SPCX $142.22 +2.95%
MU $731.55 +0.30%
AMD $511.24 -0.59%

Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc

2025-12-02 22:26:45

According to market news, Nasdaq-listed biotech company Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc.

Previously, it was reported that Hyperliquid Strategies submitted an S-1 filing to raise up to $1 billion, which may be used to purchase HYPE tokens.

ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click , and we will handle it promptly.

app_icon
ChainCatcher Building the Web3 world with innovations.